Theracos, Inc.
25Patents
18Active
25Granted
45Portfolio score
Filing activity: Apr 27, 2001 → Sep 30, 2013 · 11 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7838499B2 | Benzylbenzene derivatives and methods of use | Chemistry; Metallurgy | 25 | Active |
| US8106021B2 | Benzylbenzene derivatives and methods of use | Chemistry; Metallurgy | 20 | Active |
| US8283454B2 | Processes for the preparation of SGLT2 inhibitors | Chemistry; Metallurgy | 18 | Active |
| US7838498B2 | Benzylic glycoside derivatives and methods of use | Human Necessities | 18 | Active |
| US8987323B2 | Crystalline form of benzylbenzene SGLT2 inhibitor | Chemistry; Metallurgy | 13 | Active |
| US9006403B2 | Processes for the preparation of SGLT2 inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8802637B2 | Benzylbenzene derivatives and methods of use | Chemistry; Metallurgy | 5 | Active |
| US7105552B2 | Heterocyclic analogs of diphenylethylene compounds | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9061060B2 | Deuterated benzylbenzene derivatives and methods of use | Chemistry; Metallurgy | 3 | Active |
| US8575321B2 | Benzylbenzene derivatives and methods of use | Chemistry; Metallurgy | 2 | Active |
| US8440655B2 | Combination therapy for the treatment of diabetes | Human Necessities | 2 | Active |
| US9193751B2 | Process for the preparation of benzylbenzene SGLT2 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US6852695B2 | Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes | Human Necessities | 1 | Expired |
| US7202366B2 | Heterocyclic analogs of diphenylethylene compounds | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6855732B2 | Compounds to treat diabetes and associated conditions | Human Necessities | 1 | Expired |
| US7795228B2 | Spiroheterocyclic glycosides and methods of use | Human Necessities | 0 | Active |
| US8748419B2 | Treating obesity with muscarinic receptor M1 antagonists | Human Necessities | 0 | Active |
| US8129434B2 | Benzylphenyl cyclohexane derivatives and methods of use | Human Necessities | 0 | Active |
| US7407978B2 | Heterocyclic analogs of diphenylethylene compounds | Chemistry; Metallurgy | 0 | Expired |
| US7718682B2 | Heterocyclic analogs of diphenylethylene compounds | Chemistry; Metallurgy | 0 | Active |
| US7803778B2 | Glucose transport inhibitors and methods of use | Chemistry; Metallurgy | 0 | Active |
| US8735389B2 | Treating psychological conditions using muscarinic receptor M1 antagonists | Human Necessities | 0 | Active |
| US7893053B2 | Treating psychological conditions using muscarinic receptor M1 antagonists | Human Necessities | 0 | Active |
| US6723736B2 | Tricyclic compounds and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US7323496B2 | Compounds for treatment of inflammation, diabetes and related disorders | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.